Comparing the Effect of Combining Exercise with Rosuvastatin versus Atorvastatin on Lipid Profile and Functional Capacity: A Retrospective Cohort Study

Table 5

Crude and adjusted linear regression coefficients and 95% confidence intervals for changes in triglycerides.

Variable	Change in triglycerides
	Crude model		Simple interaction model		Fully adjusted model
		95% CI		95% CI		95% CI
Intercept	NA	NA	-0.179	(-0.385, 0.026)	-0.429	(-1.620, 0.763)
Atorvastatin use (yes)	Reference	Reference	Reference	Reference	Reference	Reference
Rosuvastatin use (yes)	0.037	(-0.085, 0.158)	0.154	(-0.130, 0.438)	-0.164	(-0.475, 0.148)
Average exercise minutes/week (minutes)	-0.0002	(-0.001, 0.001)	0.0003	(-0.001, 0.002)	0.0001	(-0.002, 0.001)
Rosuvastatin use; Average exercise interaction	NA	NA	-0.001	(-0.003, 0.001)	0.001	(-0.001, 0.003)
Age (years)	0.002	(-0.005, 0.008)	NA	NA	-0.005	(-0.014, 0.004)
Sex (male)	0.019	(-0.106, 0.144)	NA	NA	-0.051	(-0.233, 0.131)
Tobacco smoking (previous/current smoker)	0.077	(-0.175, 0.022)	NA	NA	-0.163	(-0.291, -0.035)
Other cholesterol-lowering medications (yes)	0.110	(-0.102, 0.321)	NA	NA	0.105	(-0.142, 0.353)
Anticoagulants (yes)	0.077	(-0.094, 0.248)	NA	NA	0.304	(0.022, 0.585)
Antiplatelets (yes)	0.059	(-0.113, 0.230)	NA	NA	0.099	(-0.150, 0.350)
Cardiovascular medications (yes)	-0.150	(-0.400, 0.100)	NA	NA	0.012	(-0.232, 0.257)
Oral antidiabetics (yes)	-0.019	(-0.160, 0.122)	NA	NA	-0.091	(-0.251, 0.069)
Insulin (yes)	-0.040	(-0.292, 0.211)	NA	NA	0.013	(-0.264, 0.290)
Adherence (%) to exercise schedule (weekly sessions performed/prescribed)	-0.001	(-0.005, 0.002)	NA	NA	-0.002	(-0.006, 0.003)
Weight (kg)	-0.0001	(-0.003, 0.003)	NA	NA	0.0002	(-0.004, 0.004)
Systolic BP (mmHg)	0.003	(-0.001, 0.006)	NA	NA	0.007	(0.001, 0.012)
Diastolic BP (mmHg)	0.006	(-0.0001, 0.012)	NA	NA	0.0004	(-0.008, 0.009)
6MWT at admission (meters)	0.0001	(-0.001, 0.001)	NA	NA	0.0002	(-0.001, 0.001)

6MWT: 6-minute walk test; LDL: low-density lipoprotein; HDL: high-density lipoprotein; BP: blood pressure.